Home
>
National Drug Code (NDC)
>
Gemcitabine
Gemcitabine - 25021-209-50 - (gemcitabine hydrochloride)
Drug Information of Gemcitabine
| Product NDC: | 25021-209 |
| Proprietary Name: | Gemcitabine |
| Non Proprietary Name: | gemcitabine hydrochloride |
| Active Ingredient(s): | 1 g/25mL & nbsp; gemcitabine hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gemcitabine
| Product NDC: | 25021-209 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079160 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110725 |
Package Information of Gemcitabine
| Package NDC: | 25021-209-50 |
| Package Description: | 1 VIAL in 1 CARTON (25021-209-50) > 25 mL in 1 VIAL |
NDC Information of Gemcitabine
| NDC Code | 25021-209-50 |
| Proprietary Name | Gemcitabine |
| Package Description | 1 VIAL in 1 CARTON (25021-209-50) > 25 mL in 1 VIAL |
| Product NDC | 25021-209 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | gemcitabine hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110725 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | GEMCITABINE HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | g/25mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
